1. Five drugs, including two from Novartis, win EMA endorsement —What’s next for Amarin’s stock after FDA panel recommendation — Shionogi antibiotic scores FDA ok— See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Vascular

Discussion in 'Teleflex Medical' started by anonymous, Jan 11, 2018 at 3:43 PM.

  1. anonymous

    anonymous Guest

    Can anyone fill me in on the vascular business? Would appreciate any info.
    Thank you
     
  2. anonymous

    anonymous Guest

    here’s some input-run far far away! Teletard is a joke of a company!
     
  3. anonymous

    anonymous Guest

    They also hit an all time high with their stock last week and in a five year period went from $80 per share to $280. The joke is on the uneducated.
     
  4. anonymous

    anonymous Guest

    and how much of that stock did they give to their reps? Jokes on the most underpaid medical device sales reps in the industry. Enjoy being a philanthropist.
     
  5. anonymous

    anonymous Guest

    teleflex is a Medreps best place to work . Wonder how much that cost them cause they suck
     
  6. anonymous

    anonymous Guest

    haha teletards pushing minicrap. Stryker dropped that product like they were playing hot potato
     
  7. anonymous

    anonymous Guest

    The vascular division is, by far, the best division in Teleflex. That being said, Teleflex as a whole is the worst company in the Medical Device arena. The pay is terrible, they micro manage, there is no innovation and there is no accountability from the top. The quotas are nearly unattainable and expectations are ridiculous. Did I mention the fact that there are never any new products. Do yourself a favor and look at other opportunities. Hope this answered your question